• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup

2

Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stock

3

The Pentagon said Iran War costs $29 billion,but the real cost is closer to $200 billion—and counting

1

After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup

2

Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stock

3

The Pentagon said Iran War costs $29 billion,but the real cost is closer to $200 billion—and counting
TechGoogle

Google Bans Ads for Unproven Medical Treatments. Critics Ask: What Took So Long?

By
Danielle Abril
Danielle Abril
Down Arrow Button Icon
By
Danielle Abril
Danielle Abril
Down Arrow Button Icon
September 6, 2019, 6:16 PM ET
Add Fortune on Google for similar content.

Years after ads for unproven medical treatments and therapies spread across the Internet, Google is finally cracking down on them.

The search giant said on Friday that it would prohibit ads promoting experimental medical techniques, like most stem cell and gene therapies, as well as those that have no scientific backing. The ban also includes treatments that are based on scientific findings but are too early in clinical testing for public use.

 “We have seen a rise in bad actors attempting to take advantage of individuals by offering untested, deceptive treatments,” Adrienne Biddings, a policy adviser at Google, wrote in a blog post on Friday. “Often times, these treatments can lead to dangerous health outcomes and we feel they have no place on our platforms.”

The crackdown, which will start in October, comes as health advocacy groups, the public, and government officials continue to pressure online services including Google, YouTube, and Facebook to do more to prevent the spread of health-related disinformation. Some services have been criticized for allowing the spread of anti-vaccine information, spammy health products, and miracle cures. 

Google said its previous healthcare and medicines ads policy already covered topics like anti-vaccine misinformation and miracle cures. The new rule, according to Google, extends the policy to cover scientifically unproven products and services. Google says it’s one of the first companies to introduce this type of rule. It does not apply to ads for licensed clinical trials.

Facebook is still working to better control anti-vaccination information. Earlier this week, it announced that it would roll out pop-up windows that send U.S. Instagram and Facebook users to credible sources of information if they search for or access groups or pages related to vaccines.

While Google may be at the forefront of regulating unproven therapy ads, some argue that the company is late to the game, given the proliferation of clinics peddling fake treatments, and say that there’s no clear indication of how the company will evaluate the medical ads.

“The American Medical Association believes it is critical to distinguish between treatments that have been validated by appropriate scientific study, those that are promising, and those that are without foundation,” Dr. Patrice Harris, president of the American Medical Association, said in an e-mailed statement. “We urge [Google] to make public the process they use to vet advertisements and what evidentiary standard they use for determining which treatments are appropriate to advertise.”

Google would not disclose details about how it would evaluate the ads or how many ads would be removed as a result of the new policy. The company also said is plans to continue to update its policies as the field evolves.

While many medical experts laud the rule’s existence, some want to know: What took so long?

The rise of fraudulent stem cell and gene therapy clinics began nearly 10 years ago, mostly driven by unregulated countries, said Sean Morris, chairman of the Society of Stem Cell Research. Those clinics sometimes bought ads targeting U.S. customers for their fake cures. Over time, some were able to open up shop in the U.S. and sell their products domestically. 

“This is a huge problem here,” Morris said. “There are all kinds of companies that have sprung up across the U.S. selling therapies to desperate patients. They’re promising to cure diseases that can’t be cured.”

Last year, the Food and Drug Administration announced that it was taking action against “unscrupulous actors” in the field, beginning with two U.S. stem cell clinics. Many in the medical field say the action was long overdue. And because of the delayed response, now hundreds of clinics operate in the U.S., Morris said. 

“That emboldened people,” he said. “These companies are just trying to stay one step ahead of the FDA by altering their claims and slightly changing their products.”

Regarding Google’s latest effort, Morris said: “These ads have been present on the Internet for at least 15 years—at least. But better late than never.”

More must-read stories from Fortune:

—Android 10’s 7 most anticipated new features
—This new app puts deepfake technology in the hands of a mainstream audience
—Google hit with a record fine by the FTC for violating children’s privacy on YouTube
—A U.K court may have made police use of facial recognition easier
—Porsche unveils its first-ever electric car
Catch up with Data Sheet, Fortune’s daily digest on the business of tech.

About the Author
By Danielle Abril
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in Tech

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Tech

Current price of Ethereum for June 24, 2026
Personal FinanceEthereum
Current price of Ethereum for June 24, 2026
By Joseph HostetlerJune 24, 2026
37 minutes ago
Taktile cofounders Maik Taro Wehmeyer (left) and Maximilian Eber (right) stand side by side, smiling at the camera.
Startups & VentureVenture Capital
Exclusive: Taktile raises $110 million from Goldman Sachs, Tiger Global to automate high-stakes financial decisions 
By Camila Grigera NaónJune 24, 2026
41 minutes ago
Sarah Youngwood, EVP and CFO at Nasdaq.
AICFO Daily
Nasdaq’s CFO says leaders must learn AI—not just their teams
By Sheryl EstradaJune 24, 2026
55 minutes ago
steve
Commentary250 Years of Innovation
Steve Case: America was built by entrepreneurs. Here’s how we keep that edge for the next 250 years
By Steve CaseJune 24, 2026
1 hour ago
(left to right) Andrew Berman, Tal Peretz, and Vitor Balocco
AIVenture Capital
Exclusive: Vinod Khosla wanted ‘every available dollar’ of Runlayer’s funding round. It just raised $30 million to govern the agent workforce
By Lily Mae LazarusJune 24, 2026
2 hours ago
t
CommentaryWhite House
Trump mistakes the bully pulpit for bullying leadership — history’s villains were never heroes
By Jeffrey Sonnenfeld and Steven TianJune 24, 2026
2 hours ago

Most Popular

After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup
By Orianna Rosa RoyleJune 23, 2026
1 day ago
Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stock
Banking
Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stock
By Jim EdwardsJune 23, 2026
1 day ago
The Pentagon said Iran War costs $29 billion,but the real cost is closer to $200 billion—and counting
Economy
The Pentagon said Iran War costs $29 billion,but the real cost is closer to $200 billion—and counting
By Jacqueline MunisJune 24, 2026
7 hours ago
Current price of oil as of June 23, 2026
Personal Finance
Current price of oil as of June 23, 2026
By Joseph HostetlerJune 23, 2026
1 day ago
Texas and Charlotte used to build huge McMansions—now they're copying the California design tricks they once mocked
Real Estate
Texas and Charlotte used to build huge McMansions—now they're copying the California design tricks they once mocked
By Sydney LakeJune 22, 2026
2 days ago
Current price of gold as of June 23, 2026
Personal Finance
Current price of gold as of June 23, 2026
By Danny BakstJune 23, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.